for August 2018
Vaccines are a gift to humanity. Soon after introduction of vaccination measles were eradicated. How good is it to not have the measles around anymore! Go to the link to see similar charts for other vaccines. Source: https://t.co/vIIchnDsVC pic.twitter.com/fjqpy24urW
— Simon Kuestenmacher (@simongerman600) August 2, 2018
“Antibiotics are among the most potent psychoactive drugs in all the pharmacopoeia. They are incredibly potent anxiolytics.They just act on the prescriber rather than the patient” -Dr. Brad Spellberg, @BradSpellberg More from @IDstewardship. #IDquotes https://t.co/yxHGlT2ko5
— Antibiotic Steward (@ABsteward) August 5, 2018
The FLUOROQUINOLONES aren't exactly safe, and the @US_FDA agrees! Think about the consequences before taking or prescribing! #ThursdayThoughts #StopSuperBugs #Stewardship https://t.co/AJLciC3wHU pic.twitter.com/iq9zfq5VDn
— Travis Jones (@tmjones6) August 2, 2018
In South Africa pharmacists are taking a bigger role in antibiotic stewardship with dramatic results. Pioneers like these are leading the effort to address antimicrobial resistance, and we want to find more like them. Find out more and get in touch here: https://t.co/wqZ9VYk2rF pic.twitter.com/csCKOOn4KL
— AMR at Wellcome (@Wellcome_AMR) August 30, 2018
NEW 🔥🔥: JAMA Clinical Guidelines Synopsis :Diagnosis and Treatment of Clostridium difficile Infection.https://t.co/Nk3WSQJwib pic.twitter.com/sPa9WgoqlH
— Antibiotic Steward (@ABsteward) August 27, 2018
NEW: A Very interesting study in CMI from 🇪🇸 Researchers to use time-to-positivity (TTP) of blood cultures as a tool for antibiotic stewardship de-escalation in patients with febrile neutropenia.#AntimicrobialStewardshiphttps://t.co/NanSUAjE6x pic.twitter.com/6vw4QqWU5d
— Antibiotic Steward (@ABsteward) August 8, 2018
Pharmacists are essential to outpatient antibiotic stewardship. SIDP position statement: https://t.co/7cRDXq611a #OutptASP pic.twitter.com/RL6AiqvDqH
— SIDP (@SIDPharm) August 14, 2018
A NEW 💥 Meta-analysis In #JACnews @BSACandJAC:Optimal treatment of MSSA bacteraemias: Cefazolin versus antistaphylococcal penicillins.
— Antibiotic Steward (@ABsteward) August 4, 2018
Significant ⬇️ in mortality w Cefazolin
No differences in clinical failure Cefazolin appeared to be better tolerated. https://t.co/cjWHyegMrm pic.twitter.com/cFcdNFF2Xw
Infection prevention & control is an essential part of @GlosHospitals #J2O. We are looking for an exceptional nurse to be Matron for IPC & Nursing Lead for Antimicrobial Stewardship https://t.co/QvPZgira8q
— Craig Bradley RN (@CraigBradleyRN) August 10, 2018
"The effects of climate are increasingly being recognized in a variety of infectious diseases, but so far as we know this is the first time it has been implicated in the distribution of antibiotic resistance over geographies,"#ActOnClimate #ClimateChange https://t.co/s4RzUJyZiD
— Paul Dawson (@PaulEDawson) August 1, 2018
Quick takes:
— Paul Sax (@PaulSaxMD) August 29, 2018
1) Important practice-changing study. ID/IM Journal Clubs, OPAT programs, take note!
2) MRSA = 0; 80% screen failures. Referral bias?
3) To review oral regimens, need the supplementary appendix.🤔
4) Presented at a cards (not ID) meeting. https://t.co/broNXcf4H4
NEW 🔥🔥: A Nice review article by @padstamundo/ @davidantibiotic
— Antibiotic Steward (@ABsteward) August 13, 2018
Treatment of Infections with OXA48 producing Enterobacteriaceaehttps://t.co/Nlnqo9Dscj @ASMicrobiology pic.twitter.com/XQI2ZOKSBS
NEW 🔥🔥:A very interesting article by @WesKufel et Al.
— Antibiotic Steward (@ABsteward) August 31, 2018
Implementation of a two-point pharmacokinetic AUC-based Vancomycin therapeutic drug monitoring approach in patients with MRSA bacteremia. Great Job.https://t.co/YBpkCJIJjq pic.twitter.com/asNBbZA4DJ
Assessing the impact of antibiotic stewardship program elements on antibiotic use across acute-care hospitals. Collaborative work from @PublicHealthON and @ICESOntariohttps://t.co/Pdxfy4LYOJ via @ICHEJournal pic.twitter.com/vFC7PfI4jB
— Brad Langford (@BRxAD) August 1, 2018
Acquisition of N. gonorrhoeae macrolide resistance through mtr alleles from other Neisseria species shows that commensal bacteria are a reservoir for antibiotic resistance @mbiojournal https://t.co/CC9NYBVP6b pic.twitter.com/fvRxyZRcVo
— ASM (@ASMicrobiology) August 9, 2018
Thanks to @FESMontemaggi for reminding me of this great @wsj visualization of measles vaccination in the US (cases per 100,000 people) https://t.co/mLLgqw2bQe pic.twitter.com/PCuRNhLMQh
— Carl Zimmer (@carlzimmer) August 9, 2018
NEW 🔥 article by @LacieMckamey
— Antibiotic Steward (@ABsteward) August 17, 2018
Assessing Antimicrobial Stewardship Initiatives: Clinical Evaluation of Cefepime or Piperacillin-tazobactam in Patients with Bloodstream Infections Secondary to AmpC Producing Organisms.https://t.co/rOVo71Kcw8 pic.twitter.com/j0Fq16blyT
NEW 🔥🔥: Review Article :Significant Publications on Infectious Diseases Pharmacotherapy in 2017 according to @SIDPharm members. https://t.co/0vHhu6QbkP pic.twitter.com/PIh63J5Eu5
— Antibiotic Steward (@ABsteward) August 13, 2018
Interesting🔥 This big study of ICU pts (>3,000) did not find an increased risk of AKI with BREIF courses of piptazo/vanco💉
— Antibiotic Tweets (@khalideljaaly) August 31, 2018
It might be fine for empiric therapy as long as we de-escalate⬇️ early. However, RCT is probably best to answer these questions.https://t.co/CrlF2os2LS pic.twitter.com/JGfFiNoOkA
Procalcitonin-guided #antibiotic therapy in critical care patients associated with improved survival (NNT=38) and reduced duration of treatment (1.2 d) in this @Crit_Care
— Brad Langford (@BRxAD) August 19, 2018
meta-analysishttps://t.co/DeKPjthbc1
This piece by the Wall Street Journal is a modern classic of #dataviz. It is abundantly clear from these heatmaps that vaccines are powerful. These charts show the number of cases per 100,000 people for all 50 states (and DC) over the past 70ish years.https://t.co/g1TlTXqGjJ pic.twitter.com/LsL8rwXv6F
— Aaron Penne (@aaronpenne) August 1, 2018
New online: Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records https://t.co/MClQMLLuIq
— The Lancet Infectious Diseases (@TheLancetInfDis) August 18, 2018
Mapping The Brain's #Microbiome: Can Studying Germs In The Brain Lead To A Cure For #Alzheimers ?
— Microbes&Infection (@MicrobesInfect) August 5, 2018
“We’re now seeing that the #brain is not sterile. It has bacteria, viruses and fungus such as yeast and even larger parasites such as amoebas.”https://t.co/7SwmiSYv78 #microbiota pic.twitter.com/2QP0BgGubG
Very interesting!
— Antibiotic Steward (@ABsteward) August 30, 2018
NEW article by @MishaDevchand & @TrubianoJason in @AAAAI_org journal :Pathways to Improved Antibiotic Allergy and Antimicrobial Stewardship Practice - The Validation of a Beta-Lactam Antibiotic Allergy Assessment Tool. https://t.co/9kG677amc6 pic.twitter.com/3X4B5hf3bk
Twenty-five institutions awarded IDSA’s Antimicrobial Stewardship Centers of Excellence (CoE) designation. https://t.co/G7NTGxYOvM pic.twitter.com/LqbRCzziRe
— IDSA (@IDSAInfo) August 7, 2018
A NEW OFID Podcast: The ID Pharmacist’s Critical Role in Improving Patient Outcomes: @PaulSaxMD Interviews @IDPharmProf@SIDPharm @accpinfdprn @IDstewardship#antibioticstewardhttps://t.co/MYiJMtjNT6
— Antibiotic Steward (@ABsteward) August 2, 2018
New systematic review: Quantifying drivers of antibiotic resistance in humans #AMR https://t.co/JjWWj0gt1J
— The Lancet Infectious Diseases (@TheLancetInfDis) August 30, 2018
A NEW🔥 large retrospective cohort study in O.F.I.D : Assessment of Inappropriate Antibiotic Use&Guideline Adherence for Uncomplicated UTI in ED &out. pt
— Antibiotic Steward (@ABsteward) August 11, 2018
Fluoroquinolones most common prescribed Ab class 😱
>75 ‰ of prescriptions Non. Recommend durationhttps://t.co/ij14JdBmye pic.twitter.com/ulTS4l6XO4
NEW prospective cohort study by @jesusrbano
— Antibiotic Steward (@ABsteward) August 30, 2018
Unsolicited consultation by ID specialist for patients with bloodstream infection.
ID consultation was associated with improved use of antibiotics&when recommendations were fully followed, with lower mortality.https://t.co/hvVO9Iafl7 pic.twitter.com/Pgefquu7xA
NEW🔥:Great article in CMI @SIDPharm @khalideljaaly
— Antibiotic Steward (@ABsteward) August 12, 2018
Contraindicated drug-drug interactions associated with oral antimicrobial agents prescribed in the ambulatory care in US
Most prevalent DD intx :
Macrolide/Statins
Fluoroquinolones / antiarrhythmic agentshttps://t.co/lEa9jeGVHK pic.twitter.com/7McZQOs0M5
A new article by Dr.Sean Avedissian @SIDPharm & @IDPharmacometrx
— Antibiotic Steward (@ABsteward) August 6, 2018
in @BSACandJAC: Measuring the impact of varying denominator definitions on standardized antibiotic consumption rates: implications for antimicrobial stewardship programmes. #JACnews https://t.co/EuMPI20uu2 pic.twitter.com/26VaUVHEIt
Our new study @ESCMID journal: https://t.co/BNH3nOnlr6
— Antibiotic Tweets (@khalideljaaly) August 12, 2018
😱1.25 million visits in US outpatients over 7 years included prescribing Abx/antifungal with a contraindicated DDI💊💥💊 Most common: clarithro/erythromycin with simva/lovastatin. Need awareness, outpatient ASP & pharmacists
NEW 🔥🔥🔥: A must read article by @jasonroberts_pk in @BSACandJAC :Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures https://t.co/0VYh5l6StP pic.twitter.com/PhwzRGqPqQ
— Antibiotic Steward (@ABsteward) August 17, 2018
NEW :Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents.
— Antibiotic Steward (@ABsteward) August 14, 2018
Failure of occurred more often in fluoroquinolone & trimethoprim-sulfamethoxazole group than in cephalosporin group #stop_fluoroquinolones_madness https://t.co/S55Qsu3dzm pic.twitter.com/FiRf7MlSRt
New ID pharmacist position open @UNMC_ID expanding #antimicrobialstewardship with me and developing an OPAT Program @nebraskamed https://t.co/1LjWXYMOq5
— bergmanscott (@bergmanscott) August 23, 2018
The Antimicrobial Stewardship Knowledge Pyramid. #pharmacists
— Antibiotic Steward (@ABsteward) August 31, 2018
Read More in @TheAJPE @JGPharmD et Al.#antibioticstewardship https://t.co/fWmPYwZvtLhttps://t.co/fWmPYwZvtL pic.twitter.com/4wTyydvpFk
NEW🔥@MayoClinic CID:Incidence of AKI among critically ill patients with brief empiric use of antipseudomonal beta-lactams with vancomycin
— Antibiotic Steward (@ABsteward) August 24, 2018
Brief exposure to PTZ/VAN did not confer a greater risk of stage 2 or 3 AKI after adjustment for relavent confounders https://t.co/sXyjplSZxI pic.twitter.com/WFgCFkfYWr
H. pylori can survive the harsh environment of the stomach, where it uses its urease enzyme to neutralize stomach acid. A new @JBacteriology study reports that urease also acts as an antioxidant. Read a summary and find a link on mBiosphere: https://t.co/26liTLGebR pic.twitter.com/zfqaXZN0XZ
— ASM (@ASMicrobiology) August 18, 2018
A NEW systematic review and meta-analysis :BL-BLI, especially PTZ, may be considered as an alternative treatment for ESBL-producing Enterobacteriaceaebloodstream infections. Only observational studies included. https://t.co/PX25NRj4Hh pic.twitter.com/l9EqMT9E7O
— Antibiotic Steward (@ABsteward) August 4, 2018
SIDP has signed on to support "Antibiotics Off the Menu", asking the six largest fast food companies to become antibiotic stewardship leaders. Join us in the fight against #antibioticresistance. Learn more here: https://t.co/56Iqqjrgi4 #antibioticsoffthemenu pic.twitter.com/eEnNR0BqsQ
— SIDP (@SIDPharm) August 30, 2018
Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials. @JGPharmD #ThematicWeek @TAEscmidhttps://t.co/fvu1HHeZWL
— Antibiotic Steward (@ABsteward) August 6, 2018
A severe disease outbreak can cause massive disruption in the health and wellbeing of a society. Investing in strong health systems that prevent, detect and contain outbreaks early will help keep the world safe from infectious diseaseshttps://t.co/Cly1BDwNRk pic.twitter.com/p1P2JOy4gf
— World Health Organization (WHO) (@WHO) August 28, 2018
Breaking News :2 days ahead of the Antimicrobial Drugs Advisory Committee Meeting,Omadacycline is not inferior to current treatments for bacterial pneumonia and skin infections.Omadacycline is a new class of antibiotics called aminomethylcyclines @SIDPharmhttps://t.co/Dsi2vxkSth
— Antibiotic Steward (@ABsteward) August 6, 2018
Check out our data project on vaccines. This is what measles looks like after the vaccine was introduced. https://t.co/pO7jquCsAW pic.twitter.com/kebReOWKr0
— Henry Williams (@digitalhen) August 15, 2018
NEW 💥 prospective cohort study by @jesusrbano :Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to gram-negative bacteria. #antibioticsteward https://t.co/vGrVTILq4Q pic.twitter.com/CUSHGVXOsF
— Antibiotic Steward (@ABsteward) August 3, 2018
Must-read on disinformation & hybrid warfare : “By playing both sides, they erode public trust in vaccination, exposing us all to the risk of infectious diseases. Viruses don’t respect national boundaries.” https://t.co/ux6quPe8PX
— Rebecca Harms (@RebHarms) August 27, 2018
Pediatric Antimicrobial Stewardship: State of the Art. A NEW review article by @Dr_Mike_Stevens. #antibioticsteward https://t.co/MS5BNAmMvA
— Antibiotic Steward (@ABsteward) August 1, 2018
New 🔥 in @ICHEJournal @SHEA_Epi
— Antibiotic Steward (@ABsteward) August 29, 2018
A noninferiority cluster-randomized controlled trial on antibiotic postprescription review and authorization by trained general #pharmacists and infectious disease clinical fellows.#antibioticstewardship https://t.co/Uw0M5Ogify pic.twitter.com/bBkyqZhcwc
NEW : Comparative incidence of AKI in hospitalized patients receiving Vanco/ PipTaz in combination or as monotherapy
— Antibiotic Steward (@ABsteward) August 10, 2018
Drug AKI
Vanco 7%
PipTazo 8.5%
Vanc/PTaz 26. 8%
Although retrospective :
AKI in PipTaz > Vanco 🤔https://t.co/DpfqQHqzqt pic.twitter.com/91a5Ib4lFJ
NEW 💥 Just published in CID
— Antibiotic Steward (@ABsteward) August 1, 2018
A Prospective Multicenter-Cohort Study found that Individual MDR risk factors can be used to guide empiric therapy for all pneumonia patients & were more important than classification of site of pneumonia into HAP VAP HCAP CAP https://t.co/agnzYZ9dfu pic.twitter.com/YslHagLcDW
What's New 🔥🔥from the CLSI Subcommittee on Antimicrobial Susceptibility Testing? By @EB_Hirsch @Contagion_Livehttps://t.co/0HYhjBApZw pic.twitter.com/bU7xlX8lWS
— Antibiotic Steward (@ABsteward) August 14, 2018
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.